Potential utility of miRNAs for liquid biopsy in breast cancer

X Liu, D Papukashvili, Z Wang, Y Liu, X Chen… - Frontiers in …, 2022 - frontiersin.org
Breast cancer (BC) remains the most prevalent malignancy due to its incidence rate,
recurrence, and metastasis in women. Conventional strategies of cancer detection …

Mechanistic effects of estrogens on breast cancer

RJ Santen, CA Stuenkel, W Yue - The Cancer Journal, 2022 - journals.lww.com
Purpose Current concepts regarding estrogen and its mechanistic effects on breast cancer
in women are evolving. This article reviews studies that address estrogen-mediated breast …

Clinicopathological Factors Associated with Oncotype DX Risk Group in patients with ER+/HER2-breast Cancer

R Song, DE Lee, EG Lee, S Lee, HS Kang, JH Han… - Cancers, 2023 - mdpi.com
Simple Summary Oncotype DX (ODX) is a gene assay that can predict the recurrence risk in
patients with early breast cancer. We aimed to evaluate clinicopathological factors that can …

[HTML][HTML] Prognostic impact of elevation of cancer antigen 15-3 (CA15-3) in patients with early breast cancer with normal serum CA15-3 level

JM Ryu, D Kang, J Cho, JE Lee, SW Kim… - Journal of Breast …, 2023 - ncbi.nlm.nih.gov
Purpose Cancer antigen 15-3 (CA15-3) is a serum tumor marker for breast cancer (BC)
extensively used in clinical practice. CA15-3 is non-invasive, easily available, and a cost …

The diversity of liquid biopsies and their potential in breast cancer management

C Keup, R Kimmig, S Kasimir-Bauer - Cancers, 2023 - mdpi.com
Simple Summary In breast cancer patients, a blood sample contains components from tumor
origin as well as those influenced by the tumor disease. Blood samples are being discussed …

Clinical and translational applications of serological and histopathological biomarkers in metastatic breast cancer: a comprehensive review

L Pekarek, A Sánchez Cendra… - International journal of …, 2023 - mdpi.com
Breast cancer is one of the most common malignancies worldwide and the most common
form of cancer in women. A large proportion of patients begin with localized disease and …

Cancer biomarkers in liquid biopsy for early detection of breast cancer: a systematic review

G Duque, C Manterola, T Otzen… - Clinical Medicine …, 2022 - journals.sagepub.com
Background: Breast cancer (BC) is the most common neoplasm in women worldwide. Liquid
biopsy (LB) is a non-invasive diagnostic technique that allows the analysis of biomarkers in …

Blood plasma circulating DNA-protein complexes: Involvement in carcinogenesis and prospects for liquid biopsy of breast cancer

A Shefer, O Tutanov, M Belenikin… - Journal of Personalized …, 2023 - mdpi.com
Circulating DNA (cirDNA) is a promising tool in translational medicine. However, studies of
cirDNA have neglected its association with proteins, despite ample evidence that this …

Comparative analysis of molecular functions and biological role of proteins from cell-free DNA-protein complexes circulating in plasma of healthy females and breast …

O Tutanov, A Shefer, Y Tsentalovich… - International Journal of …, 2023 - mdpi.com
Cell-free DNA (cfDNA) circulates in the bloodstream packed in membrane-coated structures
(such as apoptotic bodies) or bound to proteins. To identify proteins involved in the formation …

Using the DNA integrity number to analyze DNA quality in specimens collected from liquid-based cytology after fine-needle aspiration of breast tumors and lesions

A Hoshino, Y Oana, Y Ohi, Y Maeda, M Omori… - Acta Cytologica, 2024 - karger.com
Introduction: Cancer genome analysis using next-generation sequencing requires adequate
and high-quality DNA samples. Genomic analyses were conventionally performed using …